Novel Agents and Combination Regimens in Elderly Patients with CLL

There is a need for clinicians to evaluate available data from recent clinical trials and to incorporate new findings to the management of their older patient population, as appropriate.

Target Audience

This educational activity is designed to meet the needs of physicians, nurses, pharmacists, and other clinical professionals who manage patients with cancer.

Learning Objectives

Following this activity, participants should be able to:

  • Evaluate available data from recent clinical trials to incorporate new findings in CLL into the management of their older patient population
Additional information
Supporters: 

Supported by educational grants from Genentech, USA. and Gilead Sciences, Inc.

Course summary
Available credit: 
  • 0.25 Participation
  • 0.24 Nurse
  • 0.25 Pharmacist
  • 0.25 Physician
Course opens: 
10/04/2013
Course expires: 
03/01/2014
Cost:
$0.00

Andrew D. Zelenetz, MD, PhD
Memorial Sloan-Kettering Cancer Center

Available Credit

  • 0.25 Participation
  • 0.24 Nurse
  • 0.25 Pharmacist
  • 0.25 Physician

Accreditation Period

Course opens: 
10/04/2013
Course expires: 
03/01/2014

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

To access this activity, users will need:

  • A device with an Internet connection and sound playback capability
  • Adobe Flash Player and/or an HTML5 capable browser for video and audio playback
  • Adobe Reader for certificate viewing/printing